RECENT NEWS

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on proposals for indefinite recognition of CE-marked medical devices in Great Britain (GB), aimed at protecting patient access and ensuring the continued supply of safe and effective medical technologies.

Power to Disrupt : Leaders in POCT Diagnostics has unveiled the first additions to its speaker lineup. The event takes place in Birmingham on 5 May.

QuidelOrtho has entered a long-term strategic supply agreement with Chinese firm Lifotronic Technology, to expand its global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.

The Royal College of Pathology (RCPath) has submitted a response to the Medicines and Healthcare products Regulatory Agency’s (MHRA) call for evidence to help shape the work of the new National Commission on the Regulation of AI in Healthcare.

Dr Sarah Pitt, a virologist and Senior Lecturer in Biomedical Science at the University of Brighton, has been formally inaugurated as President of the Institute of Biomedical Science.

AI-powered pathology firm Path AI has announced an expansion of its support of inflammatory bowel disease clinical trials.

Leica Biosystems has launched the Leica CM1950 Cryostat with DualEcoTec Cooling System, which it says will redefine histology workflows.

Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.

Waters Corporation has announced it has completed the previously announced combination with the biosciences and diagnostic solutions businesses of Becton, Dickinson and Company (BD).

As preparations for the London Biotechnology Show 2026 continue to gain momentum, Early Bird registrations are now entering their final days. With just a few days remaining, this is the last opportunity to secure delegate access at reduced rates.

Scripps Research scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.

UC San Diego biologists have developed a new CRISPR-based technology capable of removing antibiotic-resistant elements from populations of bacteria.

The Government has unveiled its landmark National Cancer Plan, which promises patients will receive faster diagnosis, quicker treatment and the support to live well with cancer.

Aiforia Technologies has announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR.

A research team from Université de Genève has revealed how the 'hijacking' of neutrophils promotes cancer growth and could provide insights into disease progression.

An innovative bowel cancer screening test created in the north east is now being rolled out for patients elsewhere in the country.

The iFAST ONE ultra-rapid Antimicrobial Susceptibility Test (AST) system is now UKCA Certified for testing patient samples, direct from Gram-negative bacteria blood cultures.

The government has accepted advice on eligibility from the Joint Committee on Vaccination and Immunisation (JCVI) for the respiratory syncytial virus (RSV) vaccination programme.

The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research.

The Association for Diagnostics & Laboratory Medicine (ADLM) has launched a new Data Science in Laboratory Medicine Certificate Programme, designed to help clinical laboratory professionals and pathologists use healthcare data to solve challenging patient problems.